KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX, page-27

  1. 2,988 Posts.
    lightbulb Created with Sketch. 258
    Yes, this may be a turning point in the share price. A 20% drop in share price to 8 cents has seen an increase in volume selling, a capitulation moment for the last of the long holders wanting out. In any case, at these low levels it is a buy opportunity for anyone who wants in.

    Buy up more now if you want to participate in the next CR. Sell if you do not want to participate in the next CR.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.